Single-Cell & Multi-Omics Scientist

Eurofins PSS Insourcing Solutions; Cambridge (MA); On-site; USD 112,000 - 116,000; Full time

Benefits offered by this job

Medical, dental, vision benefits

401(k) with company match

Paid vacation and holidays

Life and disability insurance

Job summary

Eurofins PSS Insourcing Solutions in Cambridge, MA is seeking a passionate Single Cell Omics Scientist to generate high-quality single-cell and multi-omics data on client sites. You will work at the interface of wet-lab biology and computational science with multidisciplinary teams.

The role involves state-of-the-art single-cell assays, automation platforms, and high-throughput sequencing to drive discovery and translational programs, advancing therapeutic pipelines.

Qualifications

• Master's or doctoral degree in biological sciences or closely related field.
• Minimum 2 years of hands-on lab experience in single-cell workflows.
• Experience with major single-cell platforms (10x Genomics, Parse Biosciences, Scale).

Responsibilities

• Prepare and quality-assess high-viability single-cell samples.
• Design and execute large-scale single-cell and multi-omics workflows.
• Operate automated liquid handling and robotic systems.
• Perform library quantification and Illumina sequencing QC.
• Collaborate with experimental and data teams to plan experiments.
• Document procedures and QC metrics; generate reports.

Skills

Mammalian cell culture

Single-cell sequencing

Automation platforms

10x Genomics

Python/R

Team collaboration

Education

Master's or PhD in Biological Sciences or related

Tools

10x Genomics 3'/5' Gene Expression

10x Genomics Flex

Parse Biosciences

Scale Bio

Job description

Eurofins PSS Insourcing Solutions in Cambridge, MA is seeking a passionate Single Cell Omics Scientist to generate high-quality single-cell and multi-omics data on client sites. You will work at the interface of wet-lab biology and computational science with multidisciplinary teams.

The role involves state-of-the-art single-cell assays, automation platforms, and high-throughput sequencing to drive discovery and translational programs, advancing therapeutic pipelines.